Our story

Founded by the esteemed Professor Gunnar Ronquist, Ambusol emerged with an ambitious mission: to revolutionize the treatment of glioblastoma (GBM) and join the relentless battle against cancer. Our unwavering passion and dedication lie in developing a transformative therapy for GBM, relentlessly pursuing a deeper understanding of this formidable disease, and refining its management strategies. Through relentless innovation and unwavering research, we strive to offer hope and a brighter future for all those grappling with this debilitating illness.

Our unwavering commitment to developing effective therapies and our unwavering focus on driving meaningful change in the fight against GBM propel us to continuously challenge the frontiers of medical science and technology. We are driven by the profound belief that GBM, despite its formidable nature, can be effectively treated, and that our efforts can make a tangible difference in the lives of patients and their families.